Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives $8.24 Average Target Price from Brokerages
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has been assigned an average recommendation of “Hold” from the nine brokerages that are covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among brokerages that […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has been assigned an average recommendation of “Hold” from the nine brokerages that are covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among brokerages that […]
